Quick Takeaways
- James B. Murphy has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- No recent insider transactions are currently listed.
- Info
- Insider Ownership
Insider Trading & Ownership of James B. Murphy
- Location
- Boston, MA
- Signature
- /s/ James B. Murphy
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow James B. Murphy and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Decibel Therapeutics, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of James B. Murphy
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DBTX | Decibel Therapeutics, Inc. | Interim Chief Financial Officer Exhibit Index: 24.1 Power of Attorney | 07 Oct 2022 | |||
| MBIO | MUSTANG BIO, INC. | Interim CFO | 19 Jan 2024 |